local-green · August 8, 2026

What Cannabis Actually Does.

Not a miracle, not a menace. What the National Academies review of 10,000 studies actually found about cannabis, pain, nausea, sleep — and the real risks. 21+.

by Support LoCal Staff

LoCal Green — California cannabis: education, industry, and the people behind it.

Intended for adults 21 and over.

Not medical advice.

Two camps, both wrong.

For decades the cannabis conversation has been run by two groups who agree on nothing except that the answer is simple.

One says it is dangerous in every circumstance.

The other says it treats almost everything.

Neither survives contact with the research, which is more interesting and considerably more useful than either.

What did the most thorough review ever done find?

In 2017 the National Academies of Sciences, Engineering, and Medicine assembled an expert committee, reviewed more than 10,000 scientific abstracts, and published nearly 100 conclusions on cannabis and health.

It remains the benchmark.

They found conclusive or substantial evidence — their strongest category — for exactly three things:

Chronic pain in adults. Patients treated with cannabis or cannabinoids were more likely to experience a clinically significant reduction in pain.
Chemotherapy-induced nausea and vomiting. Oral cannabinoids are effective antiemetics — this one reached conclusive, the highest rating in the report.
Multiple sclerosis spasticity. Short-term oral cannabinoids improve patient-reported spasticity.

Three.

Out of dozens of conditions examined.

And here is the sentence that almost never gets quoted alongside those findings: for these conditions the effects of cannabinoids are modest.

In the MS trials, the average improvement in patient-reported spasticity was 0.76 points on a 0-to-10 scale.

Real, statistically significant, and small.

There was moderate evidence for improving short-term sleep in people with sleep disturbance linked to obstructive sleep apnoea, fibromyalgia, chronic pain, and MS.

For most other conditions the committee found the information inadequate to draw a conclusion — which means "not proven," not "proven ineffective."

Absence of evidence is its own category.

The distinction almost everyone misses.

Read those findings closely and a pattern appears: oral cannabinoids.

Much of the strongest evidence comes from pharmaceutical preparations — nabiximols, nabilone, dronabinol — with known doses, consistent ratios, and controlled delivery.

Not dispensary flower.

That matters enormously in practice.

A clinical trial gives a patient a measured milligram dose on a schedule.

A dispensary sells a product whose effect depends on the strain, the terpene profile, how deeply you inhale, your tolerance, whether you have eaten, and your individual metabolism.

They are related, but citing a trial of nabilone to justify a specific dispensary product is a longer leap than most marketing admits.

Several cannabinoid medicines are FDA-approved: Epidiolex, a purified CBD, for seizures in Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis complex; and dronabinol and nabilone, synthetic THC compounds, for chemotherapy nausea and appetite loss.

What is actually happening in your body?

You have an endocannabinoid system.

Most people have never heard of it, and it was only identified in the 1990s.

Your body produces its own cannabinoids that bind to receptors distributed through the brain, nervous system, and immune tissue.

That system helps regulate sleep, appetite, mood, memory, pain perception, and immune signalling — it is a general-purpose balancing mechanism rather than a single-function organ.

Cannabis contains plant cannabinoids that bind to some of the same receptors, which is why one plant produces effects across so many unrelated systems.

THC is the intoxicating compound — the one responsible for being high — and it is also the one studied for pain, nausea, and appetite.

CBD is not intoxicating.

Its strongest evidence by a wide margin is in specific rare epilepsies, where a purified pharmaceutical version is FDA-approved.

Its use for anxiety, inflammation, and pain is under active study and much of what is sold on that basis is running ahead of the evidence.

What cannabis does not do.

This part matters more than anything above it.

Cannabis does not cure cancer.

It does not cure lupus, Alzheimer's, or autoimmune disease.

It does not replace medical treatment, and anyone telling you otherwise is either misinformed or selling something.

What the evidence supports is that for some people, with some conditions, it may help manage symptoms — pain, nausea, spasticity, sleep.

Managing a symptom and treating a disease are different things.

If it helps someone eat during chemotherapy, that is genuinely valuable.

It is not the same as treating it.

The risks, stated plainly.

Responsible education covers both sides, so here is the other one.

Driving. Cannabis impairs reaction time and coordination. Driving under the influence is illegal in California and dangerous everywhere.
Anxiety and paranoia. Common with high-THC products, particularly in inexperienced users. Today's products are far more potent than those in the studies most people have heard of.
Attention and memory. Short-term impairment is well established.
Dependence. Cannabis use disorder is real. It is not equivalent to alcohol or opioid dependence, and it is not nothing.
Respiratory effects. The National Academies found regular smoking associated with more frequent chronic bronchitis and worse cough and phlegm — and that stopping is likely to improve them.
Cardiovascular. Some evidence suggests smoking cannabis may trigger a heart attack in susceptible people.
Drug interactions. Cannabinoids are processed by the same liver enzymes as many prescription medications, including some blood thinners and seizure drugs. This is not theoretical.
Adolescents and pregnancy. Both carry specific risks that adult-use research does not address.

What to do with all this.

If you are considering cannabis for a medical reason, tell your doctor or pharmacist — particularly if you take prescription medication.

Not for permission.

Because the interaction question is real and they are the only people who can answer it for your body.

If you use it recreationally and legally as an adult in California, the same practical guidance applies as with anything else: start low, know that edibles take one to two hours to take effect and catch people out constantly, do not drive, and store it where children cannot reach it.

And buy from licensed retailers.

Unlicensed products are untested, and California testing has found pesticides and heavy metals in them.

Quick answers.

What does the evidence actually show cannabis helps with?

The 2017 National Academies review of more than 10,000 scientific abstracts found conclusive or substantial evidence for exactly three things: chronic pain in adults, chemotherapy-induced nausea and vomiting, and multiple sclerosis spasticity. For those conditions the report describes the effects as modest.

Does cannabis cure cancer?

No. It does not cure cancer, lupus, Alzheimer's or autoimmune disease, and it does not replace medical treatment. What the evidence supports is that for some people, with some conditions, it may help manage symptoms — and managing a symptom is not the same as treating a disease.

Is dispensary cannabis the same as what was studied?

Largely not. Much of the strongest evidence comes from oral pharmaceutical preparations — nabiximols, nabilone, dronabinol — with known doses, consistent ratios and controlled delivery, rather than dispensary flower.

Are any cannabis medicines FDA-approved?

Yes. Epidiolex, a purified CBD, for seizures in Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis complex; and dronabinol and nabilone, synthetic THC compounds, for chemotherapy nausea and appetite loss.

What is the endocannabinoid system?

A general-purpose balancing mechanism only identified in the 1990s. The body produces its own cannabinoids that bind to receptors through the brain, nervous system and immune tissue, helping regulate sleep, appetite, mood, memory, pain perception and immune signalling.

Does CBD work for anxiety?

Its strongest evidence by a wide margin is in specific rare epilepsies, where a purified pharmaceutical version is FDA-approved. Its use for anxiety, inflammation and pain is under active study, and much of what is sold on that basis is running ahead of the evidence.

Does cannabis interact with prescription medication?

Yes, and this is not theoretical. Cannabinoids are processed by the same liver enzymes as many prescription medications, including some blood thinners and seizure drugs. Tell your doctor or pharmacist, particularly if you take prescription medication.

Why we are writing this at all.

Millions of Californians now live somewhere near a legal cannabis industry, and the information available to them is mostly marketing on one side and leftover fear on the other.

We are not here to talk anyone into anything.

We are here so that whatever people decide, they decide it knowing that the evidence is real, narrower than the advertising suggests, broader than the prohibition-era claims allowed, and still being written.

LoCal Green Principle #2 — The strongest opinions are usually built on the weakest information. Education comes first: when people understand both the benefits and the risks, they can decide what is right for them.

Primary source: the National Academies of Sciences, Engineering, and Medicine, "The Health Effects of Cannabis and Cannabinoids" (2017), plus FDA approval records. Educational information only, for adults 21 and over — not medical advice. Talk to a qualified healthcare professional about your own situation. New here? Start with Welcome to LoCal Green.